{"id":12441,"date":"2026-02-19T04:12:34","date_gmt":"2026-02-19T04:12:34","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/12441\/"},"modified":"2026-02-19T04:12:34","modified_gmt":"2026-02-19T04:12:34","slug":"novartis-to-build-manufacturing-hub-in-north-carolina-creating-700-jobs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/12441\/","title":{"rendered":"Novartis to build manufacturing hub in North Carolina, creating 700 jobs"},"content":{"rendered":"\n<p class=\"yf-vbsvxt\">ZURICH (Reuters) -Novartis will expand its operations in North Carolina and build a manufacturing hub \u200bthere as part of a planned $23 billion \u200cof U.S. infrastructure investment over the next five years, the \u200cSwiss pharmaceuticals company said on Wednesday.<\/p>\n<p class=\"yf-vbsvxt\">The expansion is projected to create 700 new positions at Novartis and more than 3,000 indirect jobs across the supply \u2060chain by 2030, \u200cthe company&#8217;s statement said.<\/p>\n<p class=\"yf-vbsvxt\">The announcement follows a preliminary deal struck by the U.S. \u200dand Swiss governments last week to cut U.S. tariffs on Switzerland to 15% from 39%.<\/p>\n<p class=\"yf-vbsvxt\">Central to the deal \u200bis a pledge by Swiss companies such as \u200cNovartis to invest $200 billion in the U.S. by the end of 2028.<\/p>\n<p class=\"yf-vbsvxt\">Novartis said the new hub, expected to open in 2027 or 2028, will comprise two new facilities in Durham, North Carolina, \u2060for biologics manufacturing and sterile \u200bpackaging, and a site \u200bin Morrisville for solid dosage production and packaging.<\/p>\n<p class=\"yf-vbsvxt\">Novartis said it will also expand its \u200dexisting Durham \u2060campus to support sterile filling of biologics.<\/p>\n<p class=\"yf-vbsvxt\">The expansion is designed to increase the company&#8217;s manufacturing \u2060capacity so that all of its key U.S. medicines can \u200cbe produced domestically, it said.<\/p>\n<p class=\"yf-vbsvxt\">(Writing by Dave \u200cGrahamEditing by David Goodman)<\/p>\n","protected":false},"excerpt":{"rendered":"ZURICH (Reuters) -Novartis will expand its operations in North Carolina and build a manufacturing hub \u200bthere as part&hellip;\n","protected":false},"author":2,"featured_media":12442,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[9152,118,206,9151],"class_list":["post-12441","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-durham","tag-north-carolina","tag-novartis","tag-pharmaceuticals-company"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/12441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=12441"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/12441\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/12442"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=12441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=12441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=12441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}